In vitro-fertilized bovine embryos were incubated in Menezo's B2 medium (MB2) supplemented with 2 mg/mL of BSA. In Exp. 1, eightcell stage embryos were allotted to one of the following groups: control medium (MB2), MB2 with 20 ngimL of platelet-activating factor (PAF), 1 x lo7 bovine blood platelets (Platelets), oviductal cells (BOEC), BOEC and 20 ng/mL of PAF (BOEC + PAF), or BOEC and 1 x lo7 platelets (BOEC + Platelets). In Exp. 2, eight-cell embryos were allotted to one of the following groups: control medium (MB2), MB2 with 1 x lo7 platelets (Platelets), 1 x lo7 platelets and 10 pgimL of platelet-derived growth factor antibody (Platelets + anti-PDGF), 1 x lo7 platelets and 1 ,ug/mL of indomethacin (Platelets + Indomethacin), or 1 x lo7 platelets and 3 ,ug/mL of mianserin (Platelets + Mianserin). Embryos were incubated at 39°C in 5% C02 in groups of five until 8 d after in vitro fertilization (IVF). In Exp. 1, Platelets stimulated embryo development to the morula, blastocyst, and expanded blastocyst stages. Embryo development was greatest in the BOEC + Platelets group on d 7 and 8 after IVF. Only embryos incubated in the BOEC + Platelets treatment group reached the hatched blastocyst stage on d 8. In Exp. 2, embryos incubated in the Platelets treatment group had the greatest ( P < .05) proportion develop beyond the eight-cell stage.
Introduction
It has been proposed, for the cow, that endometrial platelet-activating factor ( PAF) or embryo-derived PAF ( EDPAF)-activated platelets sequestered by reproductive tissues release serotonin ( 5-HT) and other factors that stimulate progesterone production (Battista et al., 1989) and account for the elevated 'This manuscript was approved for publication by the Director of the Louisiana Agric. Exp. Sta. as manuscript no. 92-11-6295. The authors are grateful to Yves MBnezo for supplying the MB2 medium and Louisiana Animal Breeders Cooperative for providing the semen.
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3T0 whom correspondence should be addressed. Received October 23, 1992 . Accepted March 3, 1993 plasma progesterone found in d-10 pregnant cows (Lukaszewska and Hansel, 1980; Lamming et al., 1989) . Stock and Hansel (1992) detected E D P M in the culture medium of some bovine embryos using an equine platelet aggregation assay. Endometrial tissues of various animals also produce PAF (Yasuda et al, 1986; Alecozay et al., 1991; Kasamo et al., 1992) .
Platelet-derived growth factor ( PDGF) stimulates luteal progesterone production (Battista et al., 1989) and plays key regulatory roles in early bovine embryo development (Larson et al., 1992c; Thibodeaux et al., 1993) . The first experiment was designed to determine whether platelets release products (possibly PDGF) that are beneficial in regulating embryonic development. Using an in vitro culture system of bovine oviductal epithelial cells ( BOEC) and bovine platelets, this experiment was designed to test the hypothesis that EDPAF or reproductive-tract PAF activates platelets sequestered within the uterus or oviduct, resulting in a release of PDGF that stimulates embryonic development.
The second experiment was designed to determine whether beneficial effects of platelets on embryo development are mediated via the release of PDGF, prostaglandins, or 5-HT. Our approach was to incubate embryos with platelets or platelets and inhibitors of PDGF (anti-PDGF), prostagladins (indomethacin), and 5-HT (mianserin).
Experimental Procedures

Culture Media and Reagents
Bovine oviducts and ovaries were transported to the laboratory in PBS (Gibco Laboratories, Grand Island, NY), and Menezo's B2 medium (MB2; API Biomeriux, France) was used as the base embryo culture medium. The culture medium for in vitro maturation ( M U ) of bovine follicular oocytes was Tissue Culture Medium-199 ( TCM-199; Gibco) supplemented with 10% fetal bovine serum ( FBS; Hyclone Laboratories, Logan, UT), antibiotics (100 units of penicillin and 100 pg of streptomycin/mL), and hormones (.01 units/ mL of purified bovine FSH and LH; NOBL Laboratories, Sioux Center, IA). Platelet-activating factor CIS ( l-0-octadecyl-2-acetyl-sn-glycero-3-phosphocholine; Boehringer Mannheim Biochemicals, Indianapolis, I N ) , indomethacin (prostaglandin endoperoxide synthase inhibitor; Sigma Chemical, St. Louis, MO), and mianserin (5-HT receptor antagonist; Sigma) were prepared fresh with each group of embryos. Indomethacin was initially resuspended in a 1,000 x stock solution in absolute ethanol and diluted with embryo culture medium immediately before use. Antibodies against PDGF (goat anti-human PDGF-AB; Upstate Biotechnology, Lake Placid, NY) were initially diluted in MB2 with 4 mg/mL of fatty acidfree BSA (Sigma Cat. No. A-60031, and stock solutions were stored at -20°C until they were used. The PDGF antibody in the present study has been described previously (Thibodeaux et al., 1993 ) and exhibits no cross-reactivity ( < .l%) with insulin-like growth factor I, transforming growth factor (TGFI-P, acidic fibroblast-growth factor (FGF), basic FGF, or epidermal growth factor (EGF) based on Western blot analysis and a biological neutralization assay.
Experimental Embryos
Embryos (eight-cell stage) were derived from rvM and in vitro fertilization (I") procedures as described by Thibodeaux et al. (1992) . Initially, ovaries were obtained from various breeds of cows and heifers slaughtered at a local abattoir and from an abattoir in South Carolina. In all cases, the ovaries reached the laboratory within 4 to 9 h after collection.
The recovered cumulus-intact oocytes aspirated from 2-to 6-mm follicles were matured in 500 pL of IVM medium in four-well plates (Nunc, Naperville, IL) for 22 to 24 h at 39°C and 5% COz in humidified air under light paraffin oil (Fisher Scientific, Fairlawn, NJ).
After the IVM period, oocytes were washed twice in B-0 medium (Brackett and Oliphant, 1975) supplemented with 20 mg/mL of BSA (Sigma Cat. No. A-4378). The oocytes were then transferred t o 50-pL drops (15 to 20 oocytes/drop) of B-0 medium containing 20 mg/mL of BSA overlaid with light paraffin oil. For IVF, one straw of frozen-thawed semen from each of two bulls was pooled and washed twice in B-0 medium (without BSA) then supplemented with 10 mM caffeine sodium benzoate (Sigma; 6 mL vol/wash) and exposed to .1 UJM Ca2+ inophore A23187 (Sigma) for 1 min. A 50-pL portion of the sperm cell suspension containing 1.5 x lo6 motile sperm cellsimL was added to the 50-pL drops of B-0 medium containing the oocytes. The oocytes and sperm cells were co-incubated at 39°C in a humidified atmosphere of 5% C02 and 95% air for 6 to 8 h. After the IVF incubation period, oocytes were washed twice in TCM-199 with 10% FBS and antibiotics, then incubated at 39°C in a humidified atmosphere of 5% COz and 95% air. The time interval from IVF until the embryos were harvested for experimental treatments was based on the length of the first four cell cycles as previously reported (Barnes and Eyestone, 1990; Barnes and First, 1991) . In the present studies, 35 to 40% of the total oocytes fertilized reached the eightcell stage within 56 to 60 h after IVF.
Isolation and Culture of Oviductal Cells
The BOEC co-culture system used was prepared as described by Thibodeaux et al. (1992 Thibodeaux et al. ( , 1993 . Cells obtained by stripping two oviducts in the early luteal stage of the estrous cycle were washed several times in TCM-199 with 10% FBS and antibiotics. After the final washing with fresh cell culture medium, portions of the cell suspension (100 pL/well) were incubated in 96-well tissue culture plates at 39°C in a humidified atmosphere of 5% C02 and allowed t o reach confluency before embryo co-culture. Oviductal epithelial cells were prepared weekly with each replicate for coculture.
Experiment 1
Eight-cell-stage bovine embryos (n = 330) were harvested from the initial culture medium 56 to 60 h after IVF. Harvested embryos were equally and randomly allotted to one of six culture treatment groups ( n = 55itreatment): control medium (MB2), MB2 with 20 ng/mL of PAF (PAF), MB2 with 1 x lo7 bovine blood platelets (Platelets), MB2 with BOEC (BOEC), MB2 with BOEC and 20 ng/mL of PAF (BOEC + PAF), or MB2 with BOEC and 1 x lo7 platelets (BOEC + Platelets). The PAF was not added directly to platelets within a single culture system; platelets aggregate after resuspension in culture medium even without the addition of PAF.
Bovine blood platelets were obtained from clinically normal Holstein heifers at various stages of the estrous cycle and prepared with each replicate of embryos as described by Battista et al. (1989) . In brief, whole blood (50 mL) containing .ll M sodium citrate (Sigma) was centrifuged (300 x g) to obtain platelet-rich plasma. The isolated platelets were washed three times in Tyrode's Buffer without Ca2+
(.14 M NaC1, 2.6 mM KC1, 12 mM NaHC03, 5.5 mM glucose, pH 7.21, supplemented with antibiotics. The number of platelets for each whole blood sample was determined using ammonium oxalate (Unopette, Becton Dickinson, Rutherford, N J ) and counted in a hemacytometer. After enumeration, platelets were centrifuged and resuspended in the embryo culture medium (MB2 with B SA) immediately before allocation to the treatment groups. Embryos in each treatment group were incubated in 96-well culture plates in 100 pL of serum-free MB2 supplemented with 2 mg/mL of fatty acid-free BSA and antibiotics. Groups of five embryos per well were maintained at 39°C in a humidified atmosphere of 5% C02 and 95% air overlaid with light paraffin oil. After embryos were assigned to treatment groups, the culture medium was not replaced and embryos remained undistributed for the remainder of the incubation period. The proportion of embryos developing beyond the eight-cell and to the morula or blastocyst stages was determined 7 d after IVF (168 h). In addition, development to the blastocyst, expanded blastocyst, or hatched blastocyst stage was determined 8 d after IVF (192 h) . A subset of embryos in each treatment group ( n = 25) was fixed and stained with a DNA-specific dye, Hoechst 33342 (Purse1 et al., 19851, after the morphological evaluations on d 8 to determine the number of nuclei in each embryo.
Experimeni 2
Eight-cell-stage embryos ( n = 275) were equally and randomly allotted t o one of the following culture groups ( n = 55hreatment): control medium consisting of MB2 (MB2), MB2 with 1 x lo7 platelets (Platelets), MB2 with 1 x lo7 platelets and 10 pLgimL of anti-PDGF (Platelets + anti-PDGF), MB2 with 1 x lo7 platelets and 1 pg/mL of indomethacin (Platelets + Indomethacin), or MB2 with 1 x lo7 platelets and 3 pg/mL of mianserin (Platelets + Mianserin). Mianserin was used to inhibit the effects of 5-HT released from platelets, as previously described by Battista et al. (1989) .
The embryos were incubated in groups of five under the same conditions as those in Exp. 1. Embryos remained undisturbed during the incubation period, and the proportion of embryos developing beyond the eight-cell and to the morula and blastocyst stage was determined 7 d after IVF. Also, development to the blastocyst, expanded blastocyst, or hatched blastocyst stage was determined 8 d after IVF.
Stat is tica 1 Analysis
Both Exp. 1 and 2 were conducted as randomized complete block designs with an experimental block consisting of a group of oocytes matured, fertilized, and resulting in eight-cell stage embryos that were randomly allotted to treatments. An experimental unit consisted of five eight-cell embryos incubated within an individual well of a 96-well culture plate. The proportions of embryos in each experimental unit that developed t o a specific stage divided by the total number of embryos in each experimental unit were analyzed using least squares procedures for unbalanced data (PROC GLM), and Tukey's test was used to determine significance among treatment means (SAS, 1985) . Effects in the model included block, treatment, and the block x treatment interaction. The numbers of nuclei per embryo were analyzed using a one-way ANOVA, and Tukey's test was used to separate treatment means.
Results and Discussion
Experiment 1
Development beyond the eight-cell stage was greater ( P < .05) in Platelets, BOEC, BOEC + PAF, and BOEC + Platelets-treated embryos than in MB2 and PAF-treated embryos ( 11.4 k 3.d aValues are means f SEM from six blocks (groups of ovaries). bMB2 = Menezo's B2 medium; PAF = platelet-activating factor; Platelets = bovine blood platelets; BOEC = bovine oviductal epithelial cells. CPercentages are cumulative values for embryos that developed beyond the eight-cell stage during the incubation period. dPercentages represent the distribution of embryos that developed to the morula or blastocyst stage at evaluation on d 7 after in vitro fertilization.
ePercentages represent the distribution of embryos that developed to the blastocyst, expanded blastocyst, or hatched blastocyst stage at evaluation on d 8 after in vitro fertilization.
f,FhMeans within a column lacking a common superscript letter differ ( P < .05). IJMeans within a column lacking a common superscript letter differ ( P < .01).
greater percentage of blastocysts on d 7 and hatched blastocysts on d 8. The platelet culture system is capable of sustaining embryonic development similar to oviductal cells, but the rate of development seems to be slower by approximately 24 h over the 8-d incubation period.
Platelet-activating factor alone or combined with oviductal cells did not affect embryonic development. Although PAF is produced endogenously by many cell types after challenge, its production is often low or undetectable without stimulation (Braquet et al., 1987) . Kasmo et al. (1992) reported that PAF concentrations in rabbit endometrial cells were almost undetectable unless they were stimulated by the Ca2+ inophore A23187 and the PAF is metabolized rapidly during culture. The absence of beneficial effects of PAF on embryonic development in this study may be due to its metabolism after its addition to oviductal cells.
Incubating embryos with BOEC alone or with a combination of BOEC and PAF or Platelets increased ( P < .05) the number of nuclei per embryo compared with MB2 and PAF (Figure 1) . A similar number of nuclei per embryo was observed for embryos in the BOEC and BOEC t Platelets treatment groups, which was greater ( P < .05) than that for embryos in the Platelets group. The number of nuclei was not different ( P > .05) between MB2, PAF, and Platelets treatment groups. Ryan et al. (1989) also failed to observe a beneficial effect of PAF on the rate of development of mouse embryos, but they reported a slight positive effect on the rate of cell division. However, PAF may also stimulate transcription of early response genes such as c-fos, as reported by Shukla (19921, and Larson et al. ( 1 9 9 2~) noted that PDGF induced expression of c-fos in bovine embryos.
Reports of PAF' production by embryos have varied, depending on species and assay techniques used.
Platelet-activating factor was undetectable in d-5 and -6 rabbit blastocysts using a platelet serotonin-release assay (Angle et al., 1988; Kasmo et al., 1992) and in mouse embryos with a RIA for PAF (Smal et al., 1990) . However, PAF' activity in the culture medium aValcles are means f SEM from six blocks (groups of ovaries). bMB2 = Menezo's B2 medium; Platelets = bovine blood platelets; anti-PDGF = platelet-derived growth factor antibodies. CPercentages are cumulative values for embryos that developed beyond the eight-cell stage during the incubation period. dPercentages represent the distribution of embryos that developed to the morula or blastocyst stage at evaluation on d 7 after in vitro ePercentages represent the distribution of embryos that developed to the blastocyst or expanded blastocyst stage at evaluation on d 8 after ',Weans within a column lacking a common superscript letter differ ( P < ,051.
fertilization.
in vitro fertilization.
was detected from mouse (O'Neill, 1987; Ryan et al., 1989) and human (Collier et al., 1988) embryos using a bioassay system. Stock and Hansel (1992) indicated that it was possible to measure EDPAF production in the culture media of some early bovine embryos that produced a pregnancy after their transfer to recipient females.
Experiment 2
There was approximately a 30% reduction in overall embryo development in the Platelets group for Exp. 2 compared with the results obtained for the same treatment in Exp. 1. This may have resulted because these experiments were conducted during different times of the year, and different bulls were used for the IVF .
Development beyond the eight-cell stage was greater ( P < .05) in the platelet-treated embryos than in MB2, Platelets + anti-PDGF, Platelets t Indomethacin, and Platelets + Mianserin-treated embryos (Table 2) . Development was not different ( P > .05) between embryos incubated in the MB2 and Platelets + anti-PDGF, Indomethacin, and Mianserin treatments.
Fewer ( P < .05) embryos incubated with Platelets + anti-PDGF developed to the morula stage on d 7 after rVF than did embryos incubated with Platelets. Also, development to the morula stage on d 7 was greater ( P < .05) in the Platelets treatment group than in the MB2 treatment group. Development to the blastocyst stage on d 7 after IVF did not differ ( P > .05) among treatment groups. However, a greater ( P < .05) incidence of blastocyst formation was detected on d 8 after IVF in the Platelets treatment group than in the MB2 treatment group. No differences ( P > .05) in development to the expanded blastocyst stage on d 8 after IVF were detected among treatment groups. The lack of differences on d 8 after NF among Platelets + anti-PDGF, Indomethacin, and Mianserin treatment groups may be due to the concentrations of indomethacin and mianserin used. The concentrations were based on in vitro culture studies conducted with bovine luteal cells (Battista et al., 1989) .
After aggregation and degranulation, platelets release several growth factors, including TGF-6 and PDGF (Siess, 1989; Whal et al., 19891 , both of which stimulate bovine embryo development (Larson et al., 1992a,c) . Munson et al. (1992) demonstrated that TGF-0 and PDGF act synergistically t o promote proliferation of both bovine trophoblastic and endometrial epithelial cells during in vitro culture. Fibronectin and other glycoproteins are released from platelets after aggregation (Siess, 19891, and Larson et al. (1992b) found that supplementation of serumfree medium with fibronectin provided an extracellular matrix necessary for bovine embryos to develop to the blastocyst stage during in vitro culture. The platelet culture system used in the present experiments might have provided both TGF-6 and PDGF and the extracellular matrix fibronectin necessary to support embryo development during prolonged in vitro culture.
The addition of PDGF antibodies to the platelet culture system (Platelets + anti-PDGF) reduced embryonic development beyond the eight-cell stage. In a previous study (Thibodeaux et al., 19931 , we noted that the addition of PDGF antibodies to oviductal cells during co-culture initially inhibited development beyond the eight-cell stage. Although approximately 17% of the embryos were at the blastocyst stage on d 7 when anti-PDGF was added to oviductal cells, the number of inner cell mass cells per blastocyst was reduced by approximately 50% compared with blastocysts developing on oviductal cells alone (Thibodeaux et al., 1993) . The failure to detect any differences during later developmental stages may be related to the overall lower embryo development. However, PDGF antibodies added to platelets still inhibited development beyond the eight-cell stage and to the morula stage on d 7 after IVF in the present study. The exact roles of PAF' and PDGF of either embryonic or maternal origin in regulating embryonic development in vivo remain to be determined. In agreement with the findings of Larson et al. ( 1 9 9 2~) and Thibodeaux et al. (19931, these experiments indicate that growth factors released by platelets, including PDGF, stimulate early bovine embryonic development. In addition to their effects on embryonic development, various factors may affect luteal function. Indeed, 5-HT released by platelets is capable of directly stimulating progesterone production by luteal cells (Battista et al., 1989) . Early bovine embryos contain receptors for PDGF (Watson et al., 1992) and under certain conditions may produce PAF (Stock and Hansel, 1992) . Bovine embryos are also known to produce a low molecular weight factor, during later stages of development, that is capable of stimulating luteal function (Hickey and Hansel, 1987) . However, the production of various prostaglandins by bovine embryos earlier in development may also stimulate luteal function (Hwang et al., 1988; Lewis, 1989; Wilson et al., 1992) .
Implications
We have used an in vitro culture system of oviductal cells and platelets to establish a possible series of events that occur in vivo during early embryonic development. Oviductal cells seem to produce platelet-derived growth factor that stimulates embryonic development. These cells and other cells in utero may produce platelet-activating factor that elicits platelet-derived growth factor production from platelets to stimulate development. The embryo itself may produce platelet-activating factor that stimulates platelet-derived growth factor production by an autocrine mechanism. Collectively, this in vitro culture system may provide useful information on the complex series of events that occurs in vivo soon after fertilization and leads to maintenance of luteal function.
